Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysisMakoto Chuma, Shin Maeda, Toshifumi Tada et al.|Hepatology Research|2020Cited by 38
Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinomaKazuhiro Yamamoto, Koji Miyahara, Kazuhiro Nouso et al.|British Journal of Cancer|2013Cited by 37
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinibIlario Giovanni Rapposelli, Margherita Rimini, Toshifumi Tada et al.|Liver International|2021Cited by 25